Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Biological evaluation and interconversion studies of rotamers of SCH 351125, an orally bioavailable CCR5 antagonistAnandan Palani, Sherry Shapiro, John W Clader, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase ModulatorsXianhai Huang, Robert Aslanian, Wei Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent Pyrazolopyridine Series of γ-Secretase ModulatorsJun Qin, Wei Zhou, Xianhai Huang, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonistsDong Xiao, Anandan Palani, Michael Sofolarides, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2014
Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteresDong Xiao, Xiaohong Zhu, Michael Sofolarides, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase ModulatorsZhiqiang Zhao, Dmitri A Pissarnitski, Xianhai Huang, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2017
The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh<sub>2</sub> antagonistsXianhai Huang, Ashwin Rao, Wei Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitorsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Synthesis and structure-activity relationships of 2-(1,4'-bipiperidin-1'-yl)thiazolopyridine as H3 receptor antagonistsAshwin U Rao, Anandan Palani, Xiao Chen, et al.
Pageof 7